//
Cholesterol-Lowering Agents
A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association
Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients
Association Between Living in Food Deserts and Cardiovascular Risk
Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial
Advances in Coronary No-Reflow Phenomenon-a Contemporary Review
Translational Perspective on Epigenetics in Cardiovascular Disease